{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T21:27:09Z","timestamp":1781299629209,"version":"3.54.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.nmd.2016.07.010","type":"journal-article","created":{"date-parts":[[2016,7,28]],"date-time":"2016-07-28T17:16:52Z","timestamp":1469726212000},"page":"637-642","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Identifying evidence of cardio-renal syndrome in patients with Duchenne muscular dystrophy using cystatin C"],"prefix":"10.1016","volume":"26","author":[{"given":"Chet R.","family":"Villa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Kaddourah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas D.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda L.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart L.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L.","family":"Jefferies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2016.07.010_bib0010","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0960-8966(02)00140-2","article-title":"Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation","volume":"12","author":"Eagle","year":"2002","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2016.07.010_bib0015","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.nmd.2010.09.006","article-title":"Duchenne muscular dystrophy: survival by cardio-respiratory interventions","volume":"21","author":"Ishikawa","year":"2011","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2016.07.010_bib0020","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0960-8966(03)00162-7","article-title":"The Duchenne muscular dystrophy population in Denmark, 1977\u20132001: prevalence, incidence and survival in relation to the introduction of ventilator use","volume":"13","author":"Jeppesen","year":"2003","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2016.07.010_bib0025","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/ppul.23215","article-title":"Cardiac phenotype determines survival in Duchenne muscular dystrophy","volume":"51","author":"Birnkrant","year":"2016","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.nmd.2016.07.010_bib0030","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/0002-8703(94)90672-6","article-title":"Prevalence of left ventricular systolic dysfunction in Duchenne muscular dystrophy: an echocardiographic study","volume":"127","author":"de Kermadec","year":"1994","journal-title":"Am Heart J"},{"key":"10.1016\/j.nmd.2016.07.010_bib0035","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001338","article-title":"Myocardial fibrosis burden predicts left ventricular ejection fraction and is associated with age and steroid treatment duration in duchenne muscular dystrophy","volume":"4","author":"Tandon","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.nmd.2016.07.010_bib0040","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nmd.2016.07.010_bib0045","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0735-1097(99)00608-7","article-title":"The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction","volume":"35","author":"Dries","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nmd.2016.07.010_bib0050","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1161\/CIRCHEARTFAILURE.112.966960","article-title":"Cystatin C identifies patients with stable chronic heart failure at increased risk for adverse cardiovascular events","volume":"5","author":"Dupont","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.nmd.2016.07.010_bib0055","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1007\/s00467-015-3165-8","article-title":"Prevalence, predictors, and outcomes of cardiorenal syndrome in children with dilated cardiomyopathy: a report from the Pediatric Cardiomyopathy Registry","volume":"30","author":"Kaddourah","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nmd.2016.07.010_bib0060","doi-asserted-by":"crossref","first-page":"211","DOI":"10.5692\/clinicalneurol.52.211","article-title":"Renal dysfunction is a frequent complication in patients with advanced stage of Duchenne muscular dystrophy","volume":"52","author":"Matsumura","year":"2012","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.nmd.2016.07.010_bib0065","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.nmd.2015.01.005","article-title":"Renal function in children and adolescents with Duchenne muscular dystrophy","volume":"25","author":"Braat","year":"2015","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2016.07.010_bib0070","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.nmd.2015.07.006","article-title":"Treatable renal failure found in non-ambulatory Duchenne muscular dystrophy patients","volume":"25","author":"Motoki","year":"2015","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2016.07.010_bib0075","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.nmd.2012.07.009","article-title":"Growth hormone treatment in boys with Duchenne muscular dystrophy and glucocorticoid-induced growth failure","volume":"22","author":"Rutter","year":"2012","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2016.07.010_bib0080","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD","volume":"20","author":"Schwartz","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nmd.2016.07.010_bib0085","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/00365510410003723","article-title":"Calculation of glomerular filtration rate expressed in mL\/min from plasma cystatin C values in mg\/L","volume":"64","author":"Larsson","year":"2004","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.nmd.2016.07.010_bib0090","article-title":"A randomized, double-blind trial of lisinopril and losartan for the treatment of cardiomyopathy in duchenne muscular dystrophy","volume":"5","author":"Allen","year":"2013","journal-title":"PLoS Curr"},{"key":"10.1016\/j.nmd.2016.07.010_bib0095","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000349966","article-title":"Pathophysiology of the cardiorenal syndromes: executive summary from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI)","volume":"182","author":"McCullough","year":"2013","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.nmd.2016.07.010_bib0100","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1161\/CIRCULATIONAHA.109.886473","article-title":"Cardiorenal syndrome: new perspectives","volume":"121","author":"Bock","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.nmd.2016.07.010_bib0105","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1161\/01.CIR.0000116764.53225.A9","article-title":"Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study","volume":"109","author":"McAlister","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.nmd.2016.07.010_bib0110","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/mus.21420","article-title":"Utility of cystatin C to monitor renal function in duchenne muscular dystrophy","volume":"40","author":"Viollet","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2016.07.010_bib0115","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s12253-009-9243-0","article-title":"Differential effect of corticosteroids on serum cystatin C in thrombocytopenic purpura and leukemia","volume":"16","author":"Bardi","year":"2010","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.nmd.2016.07.010_bib0120","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1373\/clinchem.2007.094946","article-title":"Effect of corticosteroid therapy on low-molecular weight protein markers of kidney function","volume":"53","author":"Bokenkamp","year":"2007","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.nmd.2016.07.010_bib0125","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003725.pub3","article-title":"Glucocorticoid corticosteroids for Duchenne muscular dystrophy","author":"Manzur","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nmd.2016.07.010_bib0130","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1212\/WNL.0000000000002337","article-title":"Practice guideline update summary: corticosteroid treatment of Duchenne muscular dystrophy: report of the Guideline Development Subcommittee of the American Academy of Neurology","volume":"86","author":"Gloss","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2016.07.010_bib0135","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1474-4422(14)70318-7","article-title":"Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: a randomised, double-blind, placebo-controlled trial","volume":"14","author":"Raman","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nmd.2016.07.010_bib0140","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S1474-4422(14)70195-4","article-title":"Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 study","volume":"13","author":"Voit","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nmd.2016.07.010_bib0145","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1474-4422(09)70272-8","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care","volume":"9","author":"Bushby","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nmd.2016.07.010_bib0150","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00467-012-2341-3","article-title":"Performance of cystatin C-based equations in a pediatric cohort at high risk of kidney injury","volume":"28","author":"Nehus","year":"2013","journal-title":"Pediatr Nephrol"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896616302292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896616302292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:04:31Z","timestamp":1760774671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896616302292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0960896616302292"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2016.07.010","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identifying evidence of cardio-renal syndrome in patients with Duchenne muscular dystrophy using cystatin C","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2016.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}